ATC Group: S01BC03 Diclofenac

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01BC03 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01B Antiinflammatory agents
4 S01BC Antiinflammatory agents, non-steroids
5 S01BC03 Diclofenac

Active ingredients in S01BC03

Active Ingredient Description
Diclofenac

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Cyprus (CY)

Finland (FI)

Hong Kong (HK)

Israel (IL)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

Nigeria (NG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.